The longer a person has type 2 diabetes, the greater the risk of cardiovascular disease. A new study from Karolinska Institutet, published in the journal Diabetes, shows that changes in red blood ...

A new study maps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in ...

About one in five patients with cancer who undergo genetic testing are incidentally found to have mutations in their blood ...

Kavita Mehta is pinning her hopes on 2026 for a cure to a major blood disorder, following a breakthrough gene-editing treatment on the NHS. Ms Mehta, 36, from London, suffers from beta thalassaemia, a ...

Preliminary but promising.Those three words emerged as a recurring theme in conversations about several abstracts presented at this year’s ASH Annual Meeting and Exposition that examined the effects ...

A groundbreaking oral treatment for thalassemia, Mitapivat, has received US FDA approval, offering hope for adults with this ...

King Faisal Specialist Hospital & Research Centre continues to strengthen its position as a leading referral center for pediatric hematology and oncology through a comprehensive care model built on ...

King Faisal Specialist Hospital & Research Centre continues to advance pediatric care through specialized programs dedicated to solid tumors and non-malignant blood disorders, supported by ...

Explore specialized training for nurse practitioners in hematology, aiding advanced cancer care and addressing patient needs.

Here are the top 5 articles detailing the advancements in hematologic oncology from 2025. BTK inhibitors have revolutionized ...

Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...

ORLANDO, Fla.—Novartis is divulging details from ianalumab’s summertime phase 3 win in a rare autoimmune blood disorder, and the data suggest the treatment could delay the progression of patients to ...